The ε isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease

Journal of Neuropathology and Experimental Neurology

Volumn 66, Issue 2, 2007, Pages 124-130

  Di Fede, Giuseppe ^a   Giaccone, Giorgio ^a   Limido, Lucia ^a   Mangieri, Michela ^a   Suardi, Silvia ^a   Puoti, Gianfranco ^b   Morbin, Michela ^a   Mazzoleni, Giulia ^a   Ghetti, Bernardino ^c   Tagliavini, Fabrizio ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c INDIANA UNIVERSITY   (United States)

Author keywords

14 3 3; Amyloid; Creutzfeldt Jakob disease; Gerstmann Str ussler Scheinker disease; Prion protein

Indexed keywords

AMYLOID PROTEIN; ISOPROTEIN; PRION PROTEIN; PROTEIN 14 3 3; PROTEIN 14 3 3 EPSILON; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; ULTRASTRUCTURE; WESTERN BLOTTING; ANTIBODY SPECIFICITY; BRAIN; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PRION; SENILE PLAQUE;

14-3-3 PROTEINS; ANTIBODY SPECIFICITY; BIOLOGICAL MARKERS; BRAIN; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSIS, DIFFERENTIAL; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; NEURONS; PREDICTIVE VALUE OF TESTS; PRIONS; SENILE PLAQUES;

EID: 33846811283     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/nen.0b013e3180302060     Document Type: Article

References (35)

1. Prusiner SB. The prion diseases. Brain Pathol 1998;8:499-513
2. Tagliavini F, Prelli F, Porro M, et al. Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 1994;79:695-703
3. Piccardo P, Dlouhy SR, Lievens PM, et al. Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 1998;57:979-88
4. Berg D, Holzmann C, Riess O. 14-3-3 proteins in the nervous system. Nat Rev Neurosci 2003;4:752-62
5. Aitken A. Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants. Plant Mol Biol 2002;50;993-1010
6. Williams NG, Roberts TM. Signal transduction pathways involving the Raf proto-oncogene. Cancer Metastasis Rev 1994;13:105-16
7. Xiao B, Smerdon SJ, Jones DH, et al. Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature 1995;376:188-91
8. Boston PF, Jackson P, Thompson RJ. Human 14-3-3 protein: Radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders. J Neurochem 1982;38:1475-82
9. Burkhard PR, Sanchez JC, Landis T, et al. CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology 2001;56:1528-33
10. Collins S, Boyd A, Fletcher A, et al. Creutzfeld-Jakob disease: Diagnostic utility of 14-3-3 immunodetection in cerebrospinal fluid. J Clin Neurosci 2000;7:203-8
11. Wiltfang J, Otto M, Baxter HC, et al. Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurochem 1999;73:2485-90
12. Richard M, Biacabe AG, Streichenberger N, et al. Immunohistochemical localization of 14-3-3 ζ protein in amyloid plaques in human spongiform encephalopathies. Acta Neuropathol 2003;105:296-302
13. Layfield R, Fergusson J, Aitken A, et al. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins. Neurosci Lett 1996;209:57-60
14. Komori T, Ishizawa K, Arai N, et al. Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy. Acta Neuropathol (Berl) 2003;106:66-70
15. Rossi G, Giaccone G, Giampaolo L, et al. Creutzfeldt-Jakob disease with a novel four extra-repeat insertional mutation in the PrP gene. Neurology 2000;55:405-10
16. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-33
17. Baxter HC, Fraser JR, Liu WG, et al. Specific 14-3-3 isoform detection and immunolocalization in prion diseases. Biochem Soc Trans 2002;30:387-91
18. Kawamoto Y, Akiguchi I, Jarius C, et al. Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains. Acta Neuropathol (Berl) 2004;108:302-8
19. 2+-activated Cl-channel by 14-3-3 ε. Biochem Biophys Res Commun 2000;270:581-87
20. Booij PP, Roberts MR, Vogelzang SA, et al. 14-3-3 proteins double the number of outward-rectifying K+ channels available for activation in tomato cells. Plant J 1999;20:673-83
21. Basu S, Totty NF, Irwin MS, et al. Akt phophorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 2003;11:11-23
22. Xing H, Zhang S, Weinheimer C, et al. 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J 2000;19:349-58
23. van Hemert MJ, Steensma HY, van Heusden GP. 14-3-3 proteins: Key regulators of cell division, signalling and apoptosis. Bioessays 2001;23:936-46
24. Toyo-oka K, Shionoya A, Gambello MJ, et al. 14-3-3ε is important for neuronal migration by binding to NUDEL: A molecular explanation for Miller-Dieker syndrome. Nat Genet 2003;34:274-85
25. Niu J, Scheschonka A, Druey KM, et al. RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling domain). Biochem J 2002;365:677-84
26. Takahashi Y. The 14-3-3 proteins: Gene, gene expression, and function. Neurochem Res 2003;28:1265-73
27. Liao W, Wang S, Han C, et al. 14-3-3 proteins regulate glycogen synthase 3beta phosphorylation and inhibit cardiomyocyte hypertrophy. FEBS J 2005;272:1845-54
28. Kawamoto Y, Akiguchi I, Nakamura S, et al. Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy. Ann Neurol 2002;52:722-31
29. Xu J, Kao SY, Lee FJ, et al. Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease. Nat Med 2002;8:600-606
30. Berg D, Riess O, Bornemann A. Specification of 14-3-3 proteins in Lewy bodies. Ann Neurol 2003:53:135
31. Satoh J, Onoue H, Arima K, et al. The 14-3-3 protein forms a molecular complex with heat shock protein Hsp60 and cellular prion protein. J Neuropathol Exp Neurol 2005;64:858-68
32. Tagliavini F, Lievens PM, Tranchant C, et al. A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Straussler-Scheinker disease A117V. J Biol Chem 2001;276:6009-15
33. Parchi P, Chen SG, Brown P, et al. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Straussler-Scheinker disease. Proc Natl Acad Sci U S A 1998;95:8322-27
34. Alam R, Hachiya N, Sakaguchi M, et al. cDNA cloning and characterization of mitochondrial import stimulation factor (MSF) purified from rat liver cytosol. J Biochem (Tokyo) 1994;116:416-25
35. Moya KL, Sales N, Hassig R, et al. Immunolocalization of the cellular prion protein in normal brain. Microsc Res Tech 2000;50:58-65